• Susan Solomon
  • 14 January, 2020
  • Susan L. Solomon, JD, chief executive officer and founder of The New York Stem Cell Foundation (NYSCF) Research Institute is the recipient of the 2020 International Society for Stem Cell Research (ISSCR) Public Service Award.
    Full story
  • Goodell_SMA
  • 14 January, 2020
  • The International Society for Stem Cell Research (ISSCR) will award the Tobias Lecture Award to Margaret A. (Peggy) Goodell, PhD, Chair of the Department of Molecular and Cellular Biology and Director of the Stem Cell and Regenerative Medicine Center at Baylor College of Medicine, Houston, Texas, U.S.
    Full story
  • AllonKlein
  • 14 January, 2020
  • The International Society for Stem Cell Research (ISSCR) will award the Dr. Susan Lim Award for Outstanding Young Investigator to Allon M. Klein, PhD, Associate Professor, Systems Biology, Harvard Medical School, Boston, Mass., U.S.
    Full story
  • Mitinori Saitou

    Mitinori Saitou Earns the ISSCR Momentum Award

  • 14 January, 2020
  • The International Society for Stem Cell Research (ISSCR) present this year’s ISSCR Momentum Award to Mitinori Saitou, MD, Ph.D., Kyoto University, Japan.
    Full story
  • Rusty-Gage

    Fred H. Gage Receives the ISSCR Achievement Award

  • 14 January, 2020
  • The International Society for Stem Cell Research (ISSCR) will award its inaugural Achievement Award to Fred H. Gage, Ph.D., president of the Salk Institute for Biological Studies and the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease in Salk’s Laboratory of Genetics, La Jolla, Calif.
    Full story
  • Kym_Kilbourne

    ISSCR Hires New Director of Media and Strategic Communications

  • 13 January, 2020
  • The International Society for Stem Cell Research welcomes Kym Kilbourne as Director of Media and Strategic Communications, leading public affairs, education, member engagement, and media relations programs.
    Full story
  • ISSCR Comments on Brazil’s Advanced Therapy Medicinal Products Regulation

  • 10 October, 2019
  • The ISSCR submitted comments to Brazil’s health regulatory agency (ANVISA) regarding the proposed regulations for advanced therapy medicinal products that urge national governments to “maintain rigorous review pathways to ensure that stem cell-based products conform to the highest standards of evidence-based medicine.”
    Full story
  • The ISSCR Releases Informed Consent Standard for Stem Cell-based Interventions

  • 12 August, 2019
  • The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.
    Full story
  • Deepak Srivastava Becomes President of the ISSCR

  • 30 June, 2019
  • The ISSCR is pleased to announce Deepak Srivastava, MD, Gladstone Institutes, as the incoming president of the ISSCR and its board of directors. Srivastava assumed the post immediately following the 17th ISSCR Annual Meeting in Los Angeles, 26-29 June, 2019.
    Full story
  • The ISSCR Announces Establishment of Lawrence Goldstein Science Policy Fellowship

  • 26 June, 2019
  • The ISSCR honored longtime member Lawrence Goldstein for his years of science policy advocacy, and announced a new program in his name that will train ISSCR members to become stem cell policy advocates. The tribute and introduction of the Lawrence Goldstein Science Policy Fellowship program was part of the opening plenary session of the ISSCR annual meeting, 26-29 in Los Angeles, Calif., U.S.
    Full story
  • Leading Stem Cell Scientists Present Groundbreaking Research at Annual Meeting

  • 13 June, 2019
  • The International Society for Stem Cell Research annual meeting, 26-29 June at the Los Angeles Convention Center, will bring together more than 3,500 scientists, bioethicists, clinicians, industry professionals, and others from over 50 countries to share the latest developments in stem cell science and regenerative medicine.
    Full story
  • ISSCR Supports Amendment in U.S. Congress to Prevent Fetal Tissue Research Funding Restrictions

  • 13 June, 2019
  • The ISSCR and other medical, scientific, educational, and healthcare groups sent a letter to members of the U.S. Congress supporting an amendment that would prevent the implementation of a new policy to restrict and delay federal funding for fetal tissue research.
    Full story
  • ISSCR Applauds Landmark Court Ruling in Favor of FDA Regulating Stem Cell Therapies Offered by Florida Clinic

  • 7 June, 2019
  • The ISSCR commends the U.S. District Court ruling that confirms the FDA’s authority to regulate clinics marketing and selling unproven therapies as stem cell products. The clinic, U.S. Stem Cell, has injected cells derived from fat into the eyes of several patients, resulting in at least three being blinded.
    Full story
  • ISSCR Opposes Health and Human Services Policy Restricting Fetal Tissue Research

  • 5 June, 2019
  • The International Society for Stem Cell Research (ISSCR), the largest professional organization of stem cell researchers from around the world, opposes the new U.S. Health and Human Services policy to eliminate federal funding for fetal tissue research in the National Institutes of Health (NIH) intramural research program. This research has long been viewed as good public policy to improve human health and has proceeded with public support.
    Full story
  • ISSCR Applauds Health Canada’s New Policy Statement re Autologous Cell Therapy Products

  • 20 May, 2019
  • The ISSCR welcomes the new policy guidance from Health Canada that clarifies the regulation of autologous cell products in Canada. The new policy guidance aligns Canada’s regulations with the U.S. Food and Drug Administration’s 2017 Regenerative Medicine Framework and the Australian Therapeutic Goods Administration’s 2018 Autologous human cell and tissue product regulations.
    Full story
  • ISSCR Commends U.S. House of Representatives Committee for Approval of NIH Funding Bill

  • 10 May, 2019
  • The Appropriations Committee of the U.S. House of Representatives has approved a $2 billion increase for the National Institutes of Health (NIH) and defeated an amendment that would have prohibited federal funding for fetal tissue research.
    Full story
  • Stem Cell Therapies and Regenerative Medicine Moving Toward the Clinic

  • 2 May, 2019
  • Stem cell research is leading to potential new therapies to treat disease, with several applications in clinical trials or expected to enter trials in the coming months. These new discoveries are transforming how we think of medicine and will be key to discussions at the International Society for Stem Cell Research annual meeting, 26-29 June at the Los Angeles Convention Center.
    Full story
  • ISSCR Applauds New Japanese Rules Allowing Human-to-Animal Chimeric Embryo Research

  • 13 March, 2019
  • The ISSCR supports research using human-animal chimeras conducted under appropriate review and oversight (ISSCR Guidelines Recommendation 2.1.5) and applauds the new Japanese rules enabling research on chimeric embryos.
    Full story
  • ISSCR 2019 Election Results

  • 11 March, 2019
  • ISSCR has elected its next leadership slate, with leaders beginning their terms after the 2019 annual meeting. On behalf of all members, we extend congratulations to newly-elected officers Melissa Little, vice president; and Kenneth Zaret, treasurer, and re-appointed board members Marianne Bronner, Valentina Greco, and Arnold Kriegstein.
    Full story
    View All ISSCR News